Low HDL Cholesterol: Does Raising It Protect the Heart?

What does India's dietary study reveal about cholesterol?

The ICMR–INDIAB dietary analysis, published in Nature Medicine in September 2025, examined dietary and biochemical information from 18,090 adults. Researchers reported dyslipidaemia, meaning abnormal blood lipid levels, in approximately half of the study population. That finding describes a broader category of lipid abnormalities; it does not mean half the participants had low HDL specifically. [Original dietary study](https://www.nature.com/articles/s41591-025-03949-4).

The research was cross-sectional: it examined dietary patterns and metabolic measurements without assigning participants to different diets and following subsequent heart attacks. Its statistical models can identify associations, but cannot establish that a particular food change prevents cardiovascular events. This distinction matters when translating nutrition headlines into advice about cholesterol: improving a laboratory measurement and preventing disease are separate outcomes.

Does raising HDL cholesterol prevent heart attacks?

HDL particles help transport cholesterol toward the liver, which explains their familiar good-cholesterol label. However, a blood HDL measurement should be interpreted alongside other risk factors. The American Heart Association explicitly states that HDL is not a treatment target for reducing heart disease or stroke risk. A higher result does not cancel out concerns about LDL cholesterol or other cardiovascular risks. [American Heart Association cholesterol guide](https://www.heart.org/en/health-topics/cholesterol/your-complete-guide-to-understanding-cholesterol-and-lipids).

The randomized AIM-HIGH trial enrolled 3,414 people with established vascular disease, low HDL and elevated triglycerides whose LDL was controlled with treatment. Adding extended-release niacin increased HDL but did not reduce cardiovascular events compared with the control treatment. The trial was stopped early in 2011 because the additional treatment was unlikely to provide the expected benefit. Its findings apply to that treatment strategy and patient population; they do not mean HDL biology is irrelevant. They show why a treatment needs evidence of better health outcomes beyond an improved cholesterol number. [NHLBI explanation of AIM-HIGH](https://www.nhlbi.nih.gov/grants-and-training/aim-high-faqs).

What should patients with low HDL cholesterol do?

A low HDL result is a reason to review the complete lipid panel and the person's broader health. LDL cholesterol, triglycerides, blood pressure, diabetes, smoking and cardiovascular history help determine the appropriate prevention plan. Depending on overall risk, treatment may include cholesterol-lowering medication even when someone feels well. The American Heart Association emphasizes that LDL goals vary with a person's health and risk profile. [Understanding cholesterol results](https://www.heart.org/en/health-topics/cholesterol/your-complete-guide-to-understanding-cholesterol-and-lipids).

Practical measures include regular physical activity, avoiding tobacco and choosing meals built around vegetables, fruit, beans, whole grains, nuts and appropriate lean protein sources. These changes support cardiovascular health even when HDL moves only modestly. Supplements should not replace proven treatment, and patients should discuss niacin or other cholesterol products with their clinician before starting them. The American Heart Association does not recommend dietary supplements for cholesterol management. [Cholesterol prevention and treatment guidance](https://www.heart.org/en/health-topics/cholesterol/prevention-and-treatment-of-high-cholesterol-hyperlipidemia).